Form 4: Phreesia SVP, David Linetsky, Reports Acquisition of Restricted Stock Units in Lieu of Cash Bonus

David Linetsky, SVP at Phreesia, reports acquiring restricted stock units (RSUs) in lieu of a portion of his and his spouse's cash bonuses.

Summary

• David Linetsky, SVP of Life Sciences at Phreesia, Inc., filed a Form 4 on April 9, 2024, reporting transactions related to the acquisition of Phreesia's common stock.
• On April 5, 2024, Linetsky acquired 6,105 Restricted Stock Units (RSUs) that were fully vested upon grant, representing a portion of his cash bonus earned for the fiscal year ended January 31, 2024.
• He elected to convert 50% of his cash bonus into RSUs, receiving 115% of the earned cash bonus amount in RSUs.
• The RSUs were granted based on a per share value of $21.79, the closing price of Phreesia's common stock on April 5, 2024.
• Linetsky also reported acquiring 508 RSUs indirectly through his spouse, who also elected to convert a portion of her cash bonus into RSUs.
• Following these transactions, Linetsky directly owns 210,164 shares of common stock and indirectly owns 7,603 shares through his spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard executive compensation practices and aligns management's interests with shareholders. There are no indications of negative events or concerns.

Positives

• The acquisition of RSUs in lieu of cash bonuses demonstrates management's confidence in the company's future performance.
• The conversion of cash bonuses into RSUs aligns management's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that a senior executive is incentivized to improve the company's performance.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to align the interests of executives with those of shareholders.
• The structure of the RSU grants, where the number of units is based on the closing price of the stock on the grant date, is a standard approach.
• Many companies in the tech and healthcare sectors, such as Veeva Systems and Teladoc Health, utilize similar equity compensation plans for their executives.

Stakeholder Impact

• The RSU grants align the interests of the executive with those of the shareholders, potentially leading to increased shareholder value.
• Employees may view the equity compensation as a positive sign of the company's commitment to its leadership.

Key Dates